The activation of PI3K is induced by phosphorylation of the p85α subunit that activates mTOR through the intracellular mediator, protein kinase B (Akt), and the hyperactivated PI3K/Akt/mTOR pathway is linked with CRC progression and resistance to chemotherapy [12,13]. The gene discussed is MTOR; the disease is colorectal carcinoma.